Jianming Xu
- Genetics top 0.2%
- Estrogen and related hormone effects 88
- Cancer Research top 1%
- Molecular Biology top 0.5%
- Epigenetics and DNA Methylation 16
- RNA Research and Splicing 13
- Oncology top 1%
- Cytokine Signaling Pathways and Interactions 17
- Cancer-related Molecular Pathways 12
-
- Hormonal Regulation and Hypertension 21
-
- Reproductive System and Pregnancy 16
-
- Prostate Cancer Treatment and Research 16
Jianming Xu
202 papers receiving 12.2k citations
Hit Papers
Peers
Comparison fields: 5 of 141
- Genetics 4.3k
- Cancer Research 1.7k
- Molecular Biology 7.5k
- Oncology 2.5k
- Endocrinology, Diabetes and Metabolism 1.3k
Countries citing papers authored by Jianming Xu
This map shows the geographic impact of Jianming Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianming Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianming Xu more than expected).
Fields of papers citing papers by Jianming Xu
This network shows the impact of papers produced by Jianming Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianming Xu. The network helps show where Jianming Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jianming Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 10 | |
| 3 | 2020 | 56 | |
| 4 | 2017 | 37 | |
| 5 | 2017 | 82 | |
| 6 | 2017 | 2 | |
| 7 | 2014 | 46 | |
| 8 | 2013 | 35 | |
| 9 | 2011 | 202 | |
| 10 | 2011 | 44 | |
| 11 | 2011 | 75 | |
| 12 | 2009 | 128 | |
| 13 | Study on intestinal first pass effect and possible mechanism of omeprazole | 2009 | 1 |
| 14 | 2009 | 21 | |
| 15 | 2008 | 133 | |
| 16 | 2008 | 82 | |
| 17 | 2007 | 22 | |
| 18 | 2007 | 51 | |
| 19 | A multicenter survey on hospital inpatients with drug-induced acute liver injury in China | 2007 | 6 |
| 20 | 2002 | 32 |
About Jianming Xu
Jianming Xu is a scholar working on Genetics, Endocrinology, Diabetes and Metabolism and Oncology, having authored 204 papers that have together received 12.3k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (88 papers), Hormonal Regulation and Hypertension (21 papers), Cytokine Signaling Pathways and Interactions (17 papers), Reproductive System and Pregnancy (16 papers), Epigenetics and DNA Methylation (16 papers), Prostate Cancer Treatment and Research (16 papers), RNA Research and Splicing (13 papers) and Cancer-related Molecular Pathways (12 papers). The work is most often cited by research in Genetics (4.3k citations), Cancer Research (1.7k citations) and Molecular Biology (7.5k citations). Jianming Xu has collaborated with scholars based in United States, China and France. Frequent co-authors include Bert W. O’Malley, Lan Liao, Ming‐Jer Tsai, Qingtian Li, Wallace L. McKeehan, Sophia Y. Tsai, Ray‐Chang Wu, Li Qin, Tao He and Francesco J. DeMayo. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.